Literature DB >> 17577885

CE characterization of potential toxic labile iron in colloidal parenteral iron formulations using off-capillary and on-capillary complexation with EDTA.

Markus R Jahn1, Yahya Mrestani, Peter Langguth, Reinhard H H Neubert.   

Abstract

The present study describes the application of CZE to investigate the portion of labile iron in the following parenteral formulations: iron gluconate, iron saccharate, and iron dextran. Labile iron was detected as Fe(III)-chelate of EDTA at 246 nm. When EDTA was incubated with the formulations before electrophoresis, labile iron, or chelatable iron, respectively, was detected in all formulations, mostly in iron gluconate and iron saccharate. It was observed that the amount of iron released is time- and pH-dependent. In contrast, when EDTA was separately injected before the formulation sharp peaks of the Fe(III)-chelate were detected only after injection of iron gluconate. This type of labile iron can be described as "electrophoretically free" iron. CE provides thus a new method to characterize potential toxic, labile iron in parenteral iron formulations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17577885     DOI: 10.1002/elps.200600559

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  3 in total

Review 1.  The evolving landscape of drug products containing nanomaterials in the United States.

Authors:  Sheetal R D'Mello; Celia N Cruz; Mei-Ling Chen; Mamta Kapoor; Sau L Lee; Katherine M Tyner
Journal:  Nat Nanotechnol       Date:  2017-04-24       Impact factor: 39.213

Review 2.  Physicochemical Characterization of Iron Carbohydrate Colloid Drug Products.

Authors:  Peng Zou; Katherine Tyner; Andre Raw; Sau Lee
Journal:  AAPS J       Date:  2017-07-31       Impact factor: 4.009

3.  In vitro and in vivo DFO-chelatable labile iron release profiles among commercially available intravenous iron nanoparticle formulations.

Authors:  Amy Barton Pai; Manjunath P Pai; Dan E Meyer; Brian C Bales; Victoria E Cotero; Nan Zheng; Wenlei Jiang
Journal:  Regul Toxicol Pharmacol       Date:  2018-05-29       Impact factor: 3.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.